In 2003 The Netherlands became the first country to make standardized herbal cannabis available on prescription. Under this program, Bedrocan has acquired more than 13 years of experience, becoming an international producer of pharmaceutical-grade cannabis. Today, our products are used by patients in The Netherlands as well as Canada, Italy, Germany, Finland and the Czech Republic. We provide a range of fully standardized cannabis products to patients, each with a reproducible cannabinoid profile and independently analyzed for quality by experienced laboratories. As Bedrocan strains are used by patients, as well as qualified for use in clinical research, they have become a preferred choice for scientists and physicians who wish to study the pharmacological effects of cannabis .<br/><br/>Over the years, Bedrocan has grown from a small cultivator of medicinal cannabis into a leading organizer of cannabis research. By teaming up in 2005 with Leiden University - The Netherlands’ oldest university - Bedrocan gained access to state-of-the-art research facilities and a network of experts in a wide range of research fields. Our current network includes over 15 professional institutes, academic departments, and pharmaceutical companies worldwide. This makes the city of Leiden an important hub for cannabis-related research, ranging from fundamental chemical research and receptor-binding studies, to performing fully compliant clinical trials with herbal cannabis.<br/>Bedrocan strives to bridge the gap between patients' needs for cannabis and the quality standards of modern medicine. We do this through an active research program, a commitment to sharing our knowledge through scientific publications, and by developing research tools which provide a platform to further the independent study of cannabis. Standardization, accurate dosing, and strict safety standards are the cornerstones of medicine today. We believe herbal cannabis can, and should, meet these standards of modern medicine. Simultaneously, we use input from those who use cannabis for medical purposes to identify topics that are most important to address in this time of rapidly expanding availability of cannabis products. We call this patient-inspired research. In all we do, our challenge is to make the best choices based on patients’,needs and preferences, while using scientific data to support our final decisions on research methodology and product development.<br/>

Review of Bedrocan science: Patient-inspired and science-based

251st National Meeting (2016)

The official archive and repository for all ACS Meetings & Expositions abstracts and select posters or presentations.